跳至主要内容
临床试验/NCT03648255
NCT03648255已完成不适用

A Prospective, Observational Study to Evaluate Gastrointestinal Symptoms and Safety of an Enteral Feeding Product in Pediatric Patients With Cerebral Palsy

Abbott Nutrition19 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2018年2月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
133
试验地点
19
主要终点
Gastro-Intestinal Tolerance

研究概览

简要总结

This prospective, observational, multi-center study will follow children with cerebral palsy who decided to switch to an enteral product that contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of cerebral palsy
  • Fed with an enteral product that does not contain partially hydrolyzed protein and medium chain triglycerides and decided to be switched to an enteral product contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance
  • Fed by tube, using enteral tube feeding as sole source of nutrition
  • A signed and dated informed consent by subject's legally acceptable representative

排除标准

  • Chronic diseases other than cerebral palsy (e.g. diabetes mellitus, renal, liver, endocrine diseases, malignancy)
  • Intestinal obstruction
  • Dialysis treatment
  • Requirement of artificial ventilation
  • Requirement of parenteral nutrition
  • Normal nutrition in addition to enteral tube feeding
  • Allergy or intolerance to any ingredient of the study product
  • Currently participating in another clinical or non-clinical study

结局指标

主要结局

Gastro-Intestinal Tolerance

时间窗: Baseline to 6 months

healthcare professional assessed

次要结局

  • Anthropometrics(Baseline to 6 months)
  • Care Giver Satisfaction of Enteral Product(Baseline to 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验